Farasat S, Wei M-H, Herman M, Liewehr D J, Steinberg S M, Bale S J, Fleckman P, Toro J R
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Boulevard, Rockville, MD 20892-4562, USA.
J Med Genet. 2009 Feb;46(2):103-11. doi: 10.1136/jmg.2008.060905. Epub 2008 Oct 23.
Autosomal recessive congenital ichthyosis (ARCI) is a rare hereditary disorder of cornification. Mutations in the transglutaminase-1 (TGM1) gene, which encodes for the epidermal enzyme transglutaminase-1 (TGase-1), are one of the causes of ARCI.
The TGM1 mutation spectrum was characterised and genotype-phenotype correlations investigated in 104 patients with ARCI ascertained through the National Registry for Ichthyosis and Related Disorders in the USA. Methods: Germline mutations in TGM1 were identified in 55% (57/104) of patients with ARCI. Arginine residues in TGase-1 were mutated in 39% (22/57) of patients overall and 54% (20/37) of those with missense mutations. In total, 55% (12/22) of missense mutations were within CpG dinucleotides and 92% (11/12) of these mutations were C-->T or G-->A transitions. The genotype-phenotype investigation found that ARCI with TGM1 mutations was significantly associated with presence of collodion membrane at birth (p = 0.006), ectropion (p = 0.001), plate-like scales (p = 0.005) and alopecia (p = 0.001). Patients who had at least one mutation predicted to truncate TGase-1 were more likely to have more severe hypohidrosis (p = 0.001) and overheating (p = 0.0007) at onset of symptoms than were those with exclusively TGM1 missense mutations. A logistic model was developed, which predicted that individuals with collodion membrane, alopecia and/or eye problems are about four times more likely to have TGM1 mutations than patients without these findings.
This is the largest investigation of patients with ARCI to date. It expands the TGM1 mutation spectrum and confirms that despite genetic and phenotypic heterogeneity in ARCI, TGM1 is the main causative gene for this disorder. The high frequency of mutated arginine codons in TGM1 may be due to the deamination of CpG dinucleotides.
常染色体隐性先天性鱼鳞病(ARCI)是一种罕见的角化遗传性疾病。编码表皮转谷氨酰胺酶 -1(TGase-1)的转谷氨酰胺酶-1(TGM1)基因突变是ARCI的病因之一。
通过美国鱼鳞病及相关疾病国家登记处确定了104例ARCI患者,对其TGM1突变谱进行了特征分析,并研究了基因型与表型的相关性。方法:在55%(57/104)的ARCI患者中鉴定出TGM1的生殖系突变。总体上,39%(22/57)的患者中TGase-1的精氨酸残基发生了突变,在错义突变患者中这一比例为54%(20/37)。总共55%(12/22)的错义突变位于CpG二核苷酸内,其中92%(11/12)的这些突变是C→T或G→A转换。基因型 - 表型研究发现,伴有TGM1突变的ARCI与出生时存在胶样膜(p = 0.006)、睑外翻(p = 0.001)、板层状鳞屑(p = 0.005)和脱发(p = 0.001)显著相关。与仅存在TGM1错义突变的患者相比,至少有一个预测会截断TGase-1的突变的患者在症状发作时更易出现更严重的少汗(p = 0.001)和体温过高(p = 0.0007)。建立了一个逻辑模型,该模型预测有胶样膜、脱发和/或眼部问题的个体携带TGM1突变的可能性是没有这些表现的患者的四倍左右。
这是迄今为止对ARCI患者进行的最大规模研究。它扩展了TGM1突变谱,并证实尽管ARCI存在遗传和表型异质性,但TGM1是该疾病的主要致病基因。TGM1中精氨酸密码子的高突变频率可能是由于CpG二核苷酸的脱氨作用。